These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26799527)

  • 1. An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity.
    Fricks-Gleason AN; German CL; Hoonakker AJ; Friend DM; Ganesh KK; Carver AS; Hanson GR; Fleckenstein AE; Keefe KA
    Synapse; 2016 Apr; 70(4):139-46. PubMed ID: 26799527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.
    Frey K; Kilbourn M; Robinson T
    Eur J Pharmacol; 1997 Sep; 334(2-3):273-9. PubMed ID: 9369358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits.
    Sandoval V; Riddle EL; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1181-7. PubMed ID: 12604695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine.
    Sandoval V; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2000 Dec; 409(3):265-71. PubMed ID: 11108820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatment.
    Hanson JE; Birdsall E; Seferian KS; Crosby MA; Keefe KA; Gibb JW; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2009 Apr; 607(1-3):68-73. PubMed ID: 19326567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid and reversible change in dopamine transporters induced by methamphetamine.
    Fleckenstein AE; Metzger RR; Gibb JW; Hanson GR
    Eur J Pharmacol; 1997 Apr; 323(2-3):R9-10. PubMed ID: 9128855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regional effects of methamphetamine on dopamine transport.
    Chu PW; Seferian KS; Birdsall E; Truong JG; Riordan JA; Metcalf CS; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2008 Aug; 590(1-3):105-10. PubMed ID: 18599036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration.
    Laćan G; Hadamitzky M; Kuczenski R; Melega WP
    Synapse; 2013 Aug; 67(8):476-88. PubMed ID: 23417852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits.
    Vieira-Brock PL; McFadden LM; Nielsen SM; Ellis JD; Walters ET; Stout KA; McIntosh JM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2015 Dec; 355(3):463-72. PubMed ID: 26391161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.
    German CL; Hanson GR; Fleckenstein AE
    J Neurochem; 2012 Oct; 123(2):288-97. PubMed ID: 22804716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
    Bourque M; Liu B; Dluzen DE; Di Paolo T
    Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
    Anderson KL; Itzhak Y
    Ann N Y Acad Sci; 2006 Aug; 1074():225-33. PubMed ID: 17105919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity.
    Hozumi H; Asanuma M; Miyazaki I; Fukuoka S; Kikkawa Y; Kimoto N; Kitamura Y; Sendo T; Kita T; Gomita Y
    Toxicol Lett; 2008 Mar; 177(2):123-9. PubMed ID: 18282668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine self-administration acutely decreases monoaminergic transporter function.
    McFadden LM; Stout KA; Vieira-Brock PL; Allen SC; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    Synapse; 2012 Mar; 66(3):240-5. PubMed ID: 22120988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended access to methamphetamine self-administration up-regulates dopamine transporter levels 72 hours after withdrawal in rats.
    D'Arcy C; Luevano JE; Miranda-Arango M; Pipkin JA; Jackson JA; Castañeda E; Gosselink KL; O'Dell LE
    Behav Brain Res; 2016 Jan; 296():125-128. PubMed ID: 26367473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Gross NB; Duncker PC; Marshall JF
    Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.